EyePoint, Inc. Fair Value Assumptions, Risk Free Interest Rate (Deprecated 2018-01-31)
EyePoint, Inc. (EYPT) reported Fair Value Assumptions, Risk Free Interest Rate (Deprecated 2018-01-31) of 0.03% for the 12-month period ending 2012-06-30, per its 10-K filed 2013-09-27.
Discontinued › Notes › Fair Value Measures and Disclosures
us-gaap:FairValueAssumptionsRiskFreeInterestRate · last filed 2013-09-27
- EyePoint, Inc. fair value assumptions, risk free interest rate (deprecated 2018-01-31) for fiscal 2012 was 0.03%, a 84.21% decline from fiscal 2011.
- EyePoint, Inc. fair value assumptions, risk free interest rate (deprecated 2018-01-31) for fiscal 2011 was 0.19%.
| Period end | Fair Value Assumptions, Risk Free Interest Rate (Deprecated 2018-01-31) 12 month |
|---|---|
| 2012-06-30 | 0.03% 10-K · filed 2013-09-27 |
| 2011-06-30 | 0.19% 10-K · filed 2012-09-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |
| Seer, Inc. (SEER) | United States | $0.104B | -1.34 |
| Precipio, Inc. (PRPO) | United States | $0.043B | -36.70 |
| HARVARD BIOSCIENCE INC (HBIO) | United States | $0.037B | -2.70 |
| Bionano Genomics, Inc. (BNGO) | United States | $0.020B | -0.42 |
| ASTROTECH Corp (ASTC) | United States | $0.013B | |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |